Brief: Cosmo Announces License Of EU Rights For Lumeblue To Alfasigma

Cosmo NV

05/02/2021 06:04

Feb 5 (Reuters) - COSMO PHARMACEUTICALS NV  COPN.S :
    * ANNOUNCES LICENSE OF LUMEBLUE(TM) (METHYLENE BLUE MMX) EU
RIGHTS
TO ALFASIGMA
    * COSMO PHARMACEUTICALS NV - WILL RECEIVE A EUR4M UPFRONT
PAYMENT
FROM ALFASIGMA, PLUS DOUBLE-DIGIT ROYALTIES AND COMMERCIAL
MILESTONES
    * COSMO PHARMACEUTICALS NV - WILL BE EXCLUSIVE SUPPLIER OF
LUMEBLUE(TM)

Source text for Eikon:  ID:nTEN5x6paa 
Further company coverage:  COPN.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))